Induction therapy confers survival advantage in mechanically supported patients regardless of peak CPRA in heart transplantation

Induction therapy confers survival advantage in mechanically supported patients regardless of peak CPRA in heart transplantation

Background: There is no consensus regarding induction therapy in patients on mechanically circulatory support (MCS) listed for heart transplantation. We sought to elucidate differences in outcomes between no induction and induction. Methods: A total of 3,987 patients were analyzed from the UNOS data...

Full description

Saved in:
Bibliographic Details
Main Authors: Nataliya Bahatyrevich, MD, MS, Reid Dale, PhD, Matthew Leipzig, BSc, Katharine Casselman Pines, MPH, Shirin Jimenez, MD, Maria Currie, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:JHLT Open
Subjects:
immunosuppression
induction therapy
T-cell depleting agents
interleukin-2 receptor antagonists
mechanical circulatory support
heart transplantation
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133425000412
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items